Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Caldan Therapeutics

Caldan Therapeutics?uq=PEM9b6PF
2015 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$2.56M LATEST DEAL AMOUNT
4 INVESTORS
Description

Developer of novel therapeutics designed to treat T2 diabetes and other inflammatory diseases. The company's novel therapeutics targets free fatty acid receptors for Type 2 Diabetes (T2D) and other potential indications, enabling markets to address the market need for T2D treatments that address all aspects of the disease, including insulin resistance, pancreatic islet cell failure, inappropriate insulin secretion, and inflammation in muscle, liver and adipose tissue.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 7-11 Melville Street
  • Edinburgh EH3 7PE
  • Scotland

+44 07701 000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Caldan Therapeutics’s full profile, request a free trial.

Caldan Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 23-Jun-2017 $2.56M 00.00 00.000 Completed Generating Revenue
1. Early Stage VC (Series A) 03-Nov-2015 00.000 00.000 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Caldan Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00.0 00.0 00 00.0 00.000
To view this company’s complete Cap Table, request access »

Caldan Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Eli Lilly Corporation Minority 000 0000 000000 0
Epidarex Capital Venture Capital Minority 000 0000 000000 0
Science Ventures Venture Capital Minority 000 0000 000000 0
Scottish Enterprise Venture Capital Minority 000 0000 000000 0

Caldan Therapeutics Executive Team (5)

Name Title Board
Seat
Contact
Info
Mark Payton Ph.D Chief Executive Officer
Philip Boyd Ph.D Chief Financial Officer
Gerry Thomas Chief Operating Officer
Trond Ulven Ph.D Board Member & Co-Founder
Steve Connolly MD Vice President, Research

Caldan Therapeutics Board Members (4)

Name Representing Role Since Contact
Info
Elizabeth Roper Ph.D Caldan Therapeutics Board Member 000 0000
Graeme Milligan Caldan Therapeutics Board Member & Co-Founder 000 0000
Peter Finan Ph.D Self Board Member 000 0000
Trond Ulven Ph.D Caldan Therapeutics Board Member & Co-Founder 000 0000